Inivata is a startup based in the United Kingdom, most recent round Acquired, 1 tracked investor.
Based in the United Kingdom, Inivata is a startup. Inivata has been acquired. Brouky records 1 investor associated with the company.
Inivata is a clinical cancer genomics company that utilizes circulating tumor DNA (ctDNA) analysis to improve personalized healthcare in oncology. Its InVision platform provides advanced sequencing technology to detect genetic mutations from blood samples, aiding clinicians in treatment decisions for cancers such as non-small cell lung cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.